Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes

被引:11
|
作者
Kallash, Mahmoud [1 ]
Wang, Yujie [2 ]
Smith, Abigail [3 ]
Trachtman, Howard [4 ]
Gbadegesin, Rasheed [5 ]
Nester, Carla [6 ]
Canetta, Pietro [7 ]
Wang, Chen [7 ]
Hunley, Tracy E. [8 ]
Sperati, C. John [9 ]
Selewski, David [10 ]
Ayoub, Isabelle [11 ]
Srivastava, Tarak [12 ]
Mottl, Amy K. [13 ]
Kopp, Jeffrey [14 ]
Gillespie, Brenda [15 ]
Robinson, Bruce [3 ]
Chen, Dhruti [13 ]
Steinke, Julia [16 ]
Twombley, Katherine [10 ]
Reidy, Kimberly [17 ]
Mucha, Krzysztof [18 ,19 ]
Greenbaum, Larry A. [20 ,21 ]
Blazius, Brooke [4 ]
Helmuth, Margaret [3 ]
Yonatan, Peleg [7 ]
Parekh, Rulan S. [22 ,23 ,24 ]
Hogan, Susan [13 ]
Royal, Virginie [25 ]
D'Agati, Vivette [26 ]
Chishti, Aftab [27 ]
Falk, Ronald [13 ]
Gharavi, Ali [7 ]
Holzman, Lawrence [28 ]
Klein, Jon [29 ]
Smoyer, William [1 ]
Kretzler, Matthias [30 ]
Gipson, Debbie [4 ]
Kidd, Jason M. [31 ]
机构
[1] Nationwide Childrens Hosp, Div Pediat Nephrol, Columbus, OH USA
[2] Univ Michigan, Ann Arbor, MI USA
[3] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[4] Univ Michigan, Dept Pediat, Div Nephrol, Ann Arbor, MI USA
[5] Duke Childrens Hosp & Hlth Ctr, Dept Pediat Nephrol, Durham, NC USA
[6] Univ Iowa, Stead Family Dept Pediat, Div Pediat Nephrol Dialysis & Transplantat, Iowa, IA USA
[7] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY USA
[8] Vanderbilt Univ, Med Ctr, Div Pediat Nephrol, Nashville, TN USA
[9] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA
[10] Med Univ South Carolina, Dept Pediat Nephrol, Charleston, SC USA
[11] Ohio State Univ, Wexner Med Ctr, Dept Med, Div Nephrol, Columbus, OH USA
[12] Univ Missouri Kansas City, Sch Med, Childrens Mercy Hosp, Kansas City, MO USA
[13] Univ North Carolina, Kidney Ctr, Dept Med, Div Nephrol & Hypertens, Chapel Hill, NC USA
[14] NIDDKD, NIH, Kidney Dis Branch, Kidney Dis Sect, Bethesda, MD USA
[15] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI USA
[16] Helen DeVos Childrens Hosp, Div Med Subspecialties, Sect Pediat Nephrol, Grand Rapids, MI USA
[17] Albert Einstein Coll Med, Childrens Hosp Montefiore, Dept Pediat Nephrol, Bronx, NY USA
[18] Med Univ Warsaw, Dept Immunol Transplantol & Internal Dis, Warsaw, Poland
[19] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland
[20] Emory Univ, Dept Pediat, Div Pediat Nephrol, Atlanta, GA USA
[21] Childrens Healthcare Atlanta, Atlanta, GA USA
[22] Hosp Sick Children, Div Pediat Nephrol, Toronto, ON, Canada
[23] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON, Canada
[24] Univ Hlth Network, Dept Med, Div Nephrol, Toronto, ON, Canada
[25] Univ Montreal, Hop Maisonneuve Rosemont, Div Pathol, Montreal, PQ, Canada
[26] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA
[27] Univ Kentucky, Div Nephrol Hypertens & Renal Transplantat, Lexington, KY USA
[28] Univ Penn, Sch Med, Dept Internal Med, Philadelphia, PA USA
[29] Univ Louisville, Sch Med, Dept Med Renal, Louisville, KY USA
[30] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA
[31] Virginia Commonwealth Univ, Div Nephrol, Richmond, VA USA
关键词
focal segmental glomerulosclerosis; proteinuria; nephrotic syndrome; glomerular disease; KIDNEY-FUNCTION DECLINE; VARIANTS ASSOCIATE; NEPHROPATHY; CHILDREN; DISEASE; ADULTS;
D O I
10.2215/CJN.0000000000000069
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background FSGS is a heterogeneous diagnosis with a guarded prognosis. Polymorphisms in the apolipoprotein L1 (APOL1) gene are associated with developing FSGS and faster progression to kidney failure in affected patients. Better understanding the natural history of patients with FSGS and APOL1 risk alleles is essential to improve patient care and support the design and interpretation of interventional studies. The objective of this study was to evaluate the quantitative association between APOL1 and kidney disease progression and the interaction with other clinical and laboratory factors. Methods CureGN cohort study participants with biopsy diagnosis of FSGS, regardless of self-identified race, were included. The exposure of interest was two APOL1 risk alleles (high risk) versus zero to one risk alleles (low risk). The primary outcome was eGFR slope categorized as rapid progressor (eGFR slope #-5 ml/min per year), intermediate progressor (slope between 0 and -5), or nonprogressor (slope $0). Multivariable ordinal logistic and linear regressions were used for adjusted analyses. Missing data were addressed using multiple imputation. Results Of 650 participants, 476 (73%) had genetic testing, among whom 87 (18%) were high risk. High-risk participants were more likely to have lower median eGFR (62 [interquartile range, 36-81] versus low-risk participants 76 ml/min per 1.73 m(2) [interquartile range, 44-106]; P < 0.01). In adjusted analysis, the odds of more rapid progression of eGFR was 2.75 times higher (95% confidence interval, 1.67 to 4.53; P < 0.001) in the high-risk versus low-risk groups. Conclusions In patients with FSGS, high-risk APOL1 genotype is the predominant factor associated with more rapid loss of kidney function.
引用
收藏
页码:344 / 355
页数:12
相关论文
共 50 条
  • [41] Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts
    Santoriello, Dominick
    Husain, Syed A.
    De Serres, Sacha A.
    Bomback, Andrew S.
    Crew, Russell J.
    Vasilescu, Elena-Rodica
    Serban, Geo
    Campenot, Eric S.
    Kiryluk, Krzysztof
    Mohan, Sumit
    Hawkins, Gregory A.
    Hicks, Pamela J.
    Cohen, David J.
    Radhakrishnan, Jai
    Stokes, Michael B.
    Markowitz, Glen S.
    Freedman, Barry I.
    D'Agati, Vivette D.
    Batal, Ibrahim
    KIDNEY INTERNATIONAL, 2018, 94 (06) : 1189 - 1198
  • [42] APOL1 High-Risk Genotypes and Kidney Disease Risk in Middle-Aged Black Adults: More Questions Than Answers
    Gutierrez, Orlando M.
    KIDNEY MEDICINE, 2024, 6 (06)
  • [43] Predictors of Progression to Kidney Failure in Patients With Focal Segmental Glomerulosclerosis
    Tuttle, Katherine R.
    Daratha, Kenn B.
    Jones, Cami R.
    Kornowske, Lindsey M.
    Alicic, Radica Z.
    Bunke, Martin C.
    Thakker, Kamlesh M.
    Amari, Diana T.
    Pinto, Lionel
    Wang, Kaijun
    Norris, Keith C.
    Nicholas, Susanne B.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 504 - 504
  • [44] Human iPSC-Derived Podocytes to Study APOL1 High-Risk Variants
    Haines, Lauren
    Tran, Uyen
    O'Toole, John F.
    Sedor, John R.
    Wessely, Oliver
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 806 - 806
  • [45] Multi-Ethnic Polygenic Risk Modifies the Association Between APOL1 High Risk Genotypes and CKD
    Thi Ha My Vy
    Gulamali, Faris F.
    Nadkarni, Girish N.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 409 - 410
  • [46] Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population
    Neves, Precil
    Watanabe, Andreia
    Watanabe, Elieser
    Narcizo, Amanda
    Nunes, Kelly
    Lerario, Antonio
    Ferreira, Frederico
    Cavalcante, Livia
    Wongboonsin, Janewit
    Malheiros, Denise
    Jorge, Lecticia
    Sampson, Matthew
    Noronha, Irene
    Onuchic, Luiz
    KIDNEY INTERNATIONAL, 2024, 105 (03) : 593 - 607
  • [47] Renal and Cardiovascular Morbidities Associated with APOL1 Status among African-American and Non-African-American Children with Focal Segmental Glomerulosclerosis
    Woroniecki, Robert P.
    Ng, Derek K.
    Limou, Sophie
    Winkler, Cheryl A.
    Reidy, Kimberly J.
    Mitsnefes, Mark
    Sampson, Matthew G.
    Wong, Craig S.
    Warady, Bradley A.
    Furth, Susan L.
    Kopp, Jeffrey B.
    Kaskel, Frederick J.
    FRONTIERS IN PEDIATRICS, 2016, 4
  • [48] APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
    Parsa, Afshin
    Kao, W. H. Linda
    Xie, Dawei
    Astor, Brad C.
    Li, Man
    Hsu, Chi-yuan
    Feldman, Harold I.
    Parekh, Rulan S.
    Kusek, John W.
    Greene, Tom H.
    Fink, Jeffrey C.
    Anderson, Amanda H.
    Choi, Michael J.
    Wright, Jackson T., Jr.
    Lash, James P.
    Freedman, Barry I.
    Ojo, Akinlolu
    Winkler, Cheryl A.
    Raj, Dominic S.
    Kopp, Jeffrey B.
    He, Jiang
    Jensvold, Nancy G.
    Tao, Kaixiang
    Lipkowitz, Michael S.
    Appel, Lawrence J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23): : 2183 - 2196
  • [49] Genome-Wide Epistatic Interaction between DEF1B and APOL1 High-Risk Genotypes for Chronic Kidney Disease
    Vy, Ha My T.
    Lin, Bridget M.
    Gulamali, Faris F.
    Kooperberg, Charles
    Graff, Mariaelisa
    Wong, Jenny
    Campbell, Kirk N.
    Matise, Tara C.
    Coresh, Josef
    Thomas, Fridtjof
    Reiner, Alexander P.
    Nassir, Rami
    Schnatz, Peter F.
    Johns, Tanya
    Buyske, Steven
    Haiman, Christopher
    Cooper, Richard
    Loos, Ruth J. F.
    Horowitz, Carol R.
    Gutierrez, Orlando M.
    Do, Ron
    Franceschini, Nora
    Nadkarni, Girish N.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (10): : 1522 - 1525
  • [50] Schistosoma mansoni infection as a trigger to collapsing glomerulopathy in a patient with high-risk APOL1 genotype
    Neves, Precil D.
    Bridi, Ramaiane A.
    Ramalho, Janaina A.
    Jorge, Lecticia B.
    Watanabe, Elieser H.
    Watanabe, Andreia
    Yu, Luis
    Woronik, Viktoria
    Pinheiro, Rafaela B.
    Testagrossa, Leonardo A.
    Cavalcante, Livia B.
    Malheiros, Denise M.
    Dias, Cristiane B.
    Onuchic, Luiz F.
    PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (10): : 1 - 7